Search Results
Results found for "Bryan L. Roth"
- A new study from the Hudson Lab at the University of Glasgow shows that the FFA receptor antagonist AH7614 is actually an inverse agonist - suppressing fat cell formation, boosting lipolysis and reducing glucose uptake. Explore how targeting FFA4 could help fight metabolic disorders. Catch up with the latest research conducted in the Hudson lab in Ep. 161 of the Dr. GPCR Podcast. Subscribe to the Dr. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️https://www.ecosystem.drgpcr.com/gpcrs-in-cardiology-endocrinology-and-taste/inverse-agonism-of-the-ffa4-free-fatty-acid-receptor-controls-both-adipogenesis-and-mature-adipocyte-function #GPCR #drGPCR #FFA4 #metabolism #adipocytes” | Dr. GPCR Ecosystem
gpcrs-in-cardiology-endocrinology-and-taste/inverse-agonism-of-the-ffa4-free-fatty-acid-receptor-controls-both-adipogenesis-and-mature-adipocyte-function gpcrs-in-cardiology-endocrinology-and-taste/inverse-agonism-of-the-ffa4-free-fatty-acid-receptor-controls-both-adipogenesis-and-mature-adipocyte-function
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Authors & Affiliations "Vukadin L, Park B, Mohamed M, Li H, Elkholy A, Torrelli-Diljohn A, Kim JH, Jeong K, Murphy JM, Harvey CA, Dunlap S, Gehrs L, Lee H, Kim HG, Sah JP, Lee SN, Stanford D, Barrington RA for testing KCC-07’s ability to reactivate ADGRB1 expression involve western blotting and RT-qPCR, both
- Our History | Dr. GPCR Ecosystem
Brian Kobilka , 2012 Nobel Laureate in Chemistry.
- 🚨 Exciting Opportunity for Professionals in Drug Development! 🚨 Register today for a one-of-a-kind online course at Dr. GPCR University: "Development of GPCR Ligands as Therapeutic Drugs." 🗓 Dates: March 20 - April 10, 2025 ⏰ Time: Thursdays, 10:00 AM - 11:30 AM (EST) This advanced course is essential for anyone working in drug development and focuses on: The essentials of new drug development Key pharmacokinetic elements (absorption, distribution, clearance) Hepatic metabolism and the Cytochrome P450 system Drug safety and toxicology (including drug-drug interactions) And much more! Gain deep insights into GPCR drug candidates and learn the critical assays and techniques required to bring therapeutic molecules to life. 🚨 Only 25 spots available — register now! 💡 This is a great opportunity for both academia and industry professionals. Sessions will be live, and you’ll also have 1:1 discussion time with the instructor. Full PDFs of the slides will be available! 🔗 https://buff.ly/lVEcRUc #GPCR #DrugDevelopment #Pharmacokinetics #TherapeuticDrugs #OnlineCourse #DrGPCRUniversity #PharmaceuticalIndustry | Dr. GPCR Ecosystem
💡 This is a great opportunity for both academia and industry professionals. 💡 This is a great opportunity for both academia and industry professionals.
- Dr. GPCR Summit 2021 | Dr. GPCR Ecosystem
Make sure you have a profile picture set for both Zoom and Microsoft Teams! Cons: It may take more time to record an excellent presentation, but nothing is impossible!
- Irfan Dhanidina, Dr. Kathleen Caron and Dr. Lauren Slosky | Dr. GPCR Ecosystem
Caron, Ph.D. is the Frederik L.
- Mark Schmeizl | Dr. GPCR Ecosystem
He has successfully built numerous global life science, leadership teams, & works closely with both clients
- How GPCR Spatial Signaling Sparked a Scientific Journey | Dr. GPCR Ecosystem
It started as a summer project.A reluctant student pipetting through the day, expecting nothing more
- Dr. Jean-Philippe Pin | Dr. GPCR Ecosystem
such as the activation of cell surface receptors by intracellular proteins; the regulation of GPCRs by both
- Dr. Maria Waldhoer | Dr. GPCR Ecosystem
Even though Maria stumbled upon the GPCR field, her 20 years in both academia and in the industry working
- Chemical Probes for GPCR Imaging and Internalization with Dr. Johannes Broichhagen | Dr. GPCR Ecosystem
assay systems, and why fluorescence-based assays paired with careful synthetic planning open doors for both –2016) and later at the Max Planck Institute for Medical Research in Heidelberg, where he served as both
- Dr. Jennifer Pluznick | Dr. GPCR Ecosystem
as a postdoctoral fellow in the laboratory of Michael Caplan at Yale University, where she studied both
- Dr. Daniel Isom | Dr. GPCR Ecosystem
went on to earn a Ph.D. in Molecular Biophysics from Johns Hopkins University, followed by postdocs at both
- Jacob Lee & Jin Choe | Dr. GPCR Ecosystem
Although both went to the same college, Jacob and Jin choose different career paths.
- Dr. Nicholas Holliday | Dr. GPCR Ecosystem
Excellerate is involved in several pre-clinical drug discovery projects for both GPCR and non-GPCR targets
- Dr. Graeme Milligan | Dr. GPCR Ecosystem
Milligan is the co-founder of both Caldan Therapeutics (2015) which discovers novel therapeutics for
- Dr. Nicola J. Smith | Dr. GPCR Ecosystem
Smith’s team has made advances in the understanding of how an orphan GPCR exerts its effects both in
- Self-Learning, Collaboration, and Delegation in Science with Dr. Badr Sokrat | Dr. GPCR Ecosystem
They both discussed the intense competition in their home province, Quebec, and its impact on students Additionally, they both agreed on the importance of mentorship in building confidence, with Yamina sharing They both agreed on the value of these strategies.
- Dr. Tobi Langenhan | Dr. GPCR Ecosystem
through which I gained an M.Sc. from Somerville College and a D.Phil. from Magdalen College Oxford, both
- Dr. Kevin Pfleger | Dr. GPCR Ecosystem
I sat down with Kevin to chat about GPCRs, pharmacology, and his contributions to the field in both the
- GPCR Retreat | Dr. GPCR Ecosystem
The meeting tours through many of the major universities in the Great Lakes region in both Canada and
- Dr. Nyla Naim, Dr. Michael Lemieux & Dr. Jason Nasse | Dr. GPCR Ecosystem
Neuroscience from Ohio State University focusing on synaptic plasticity and adrenergic receptor modulation of both
- Dr. Chris Tate | Dr. GPCR Ecosystem
Chris also worked on the E. coli multidrug transporter EmrE and obtained both 2D and 3D crystals as well
- Dr. Bianca Plouffe | Dr. GPCR Ecosystem
Robert Lefkowitz , which led to the finding that both β-arrestin and G protein can simultaneously bind
- Dr. GPCR Board | Dr. GPCR Ecosystem
Maria Waldhoer "I am a pharmacologist with a ~30 years background in academia and industry, working both After a well needed break from the grind, I am now a scientific/business consultant for clients both
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
scientific journey with the award of the highly-valued Odysseus Program Type I Program Grant to work as both
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
scientific journey with the award of the highly-valued Odysseus Program Type I Program Grant to work as both
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
scientific journey with the award of the highly-valued Odysseus Program Type I Program Grant to work as both
- Custom Molecules, Fluorescent Probes: When Chemists Think Like Biologists with Dr. Maria Majellaro from Celtarys | Dr. GPCR Ecosystem
GPCR ecosystem, contributing both expertise and tools that align directly with the needs of scientists central role in the development and validation of Celtarys’ proprietary synthetic technology and is both
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
encoded reporter that facilitates visualization and quantification of aGPCR NTF-CTF separation events both the biological properties and signaling pathways activated by aGPCRs, investigating their roles in both























